Search Count: 53
 |
Crystal Structure Of Sars-Cov-2 Main Protease A173V Mutant In Complex With Leritrelvir
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.65 Å Release Date: 2026-06-03 Classification: VIRAL PROTEIN Ligands: 7ON |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2026-06-03
Ligands: 7ON
 |
Crystal Structure Of Sars-Cov-2 Main Protease P168 Deletion Mutant In Complex With Leritrelvir
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.70 Å Release Date: 2026-06-03 Classification: VIRAL PROTEIN Ligands: 7ON |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2026-06-03
Ligands: 7ON
 |
Crystal Structure Of Sars-Cov-2 Main Protease E166V Mutant In Complex With Leritrelvir
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.56 Å Release Date: 2026-06-03 Classification: VIRAL PROTEIN Ligands: 7ON, GOL |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2026-06-03
Ligands: 7ON, GOL
 |
Crystal Structure Of Sars-Cov-2 Main Protease G143S Mutant In Complex With Leritrelvir
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.97 Å Release Date: 2026-06-03 Classification: VIRAL PROTEIN Ligands: GOL, 7ON |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2026-06-03
Ligands: GOL, 7ON
 |
Crystal Structure Of Sars-Cov-2 Main Protease H172Y Mutant In Complex With Leritrelvir
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.27 Å Release Date: 2026-06-03 Classification: VIRAL PROTEIN Ligands: 7ON, GOL |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2026-06-03
Ligands: 7ON, GOL
 |
Crystal Structure Of Sars-Cov-2 Main Protease L50F/E166V Mutant In Complex With Leritrelvir
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.50 Å Release Date: 2026-06-03 Classification: VIRAL PROTEIN Ligands: A1EN0 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2026-06-03
Ligands: A1EN0
 |
Crystal Structure Of Sars-Cov-2 Main Protease M49I Mutant In Complex With Leritrelvir
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.87 Å Release Date: 2026-06-03 Classification: VIRAL PROTEIN Ligands: 7ON, GOL |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2026-06-03
Ligands: 7ON, GOL
 |
Crystal Structure Of Sars-Cov-2 Main Protease M49I/M165I Mutant In Complex With Leritrelvir
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.80 Å Release Date: 2026-06-03 Classification: VIRAL PROTEIN Ligands: A1EN0, GOL |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2026-06-03
Ligands: A1EN0, GOL
 |
Crystal Structure Of Sars-Cov-2 Main Protease M49I/M165T Mutant In Complex With Leritrelvir
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.00 Å Release Date: 2026-06-03 Classification: VIRAL PROTEIN Ligands: 7ON, GOL |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2026-06-03
Ligands: 7ON, GOL
 |
Crystal Structure Of Sars-Cov-2 Main Protease M165T Mutant In Complex With Leritrelvir
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.78 Å Release Date: 2026-06-03 Classification: VIRAL PROTEIN Ligands: A1EN0, GOL |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2026-06-03
Ligands: A1EN0, GOL
 |
Crystal Structure Of Sars-Cov-2 Main Protease S144A Mutant In Complex With Leritrelvir
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.00 Å Release Date: 2026-06-03 Classification: VIRAL PROTEIN Ligands: A1EN0, GOL |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2026-06-03
Ligands: A1EN0, GOL
 |
Crystal Structure Of Sars-Cov-2 Main Protease T21I/E166V Mutant In Complex With Leritrelvir
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.95 Å Release Date: 2026-06-03 Classification: VIRAL PROTEIN Ligands: 7ON, GOL |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2026-06-03
Ligands: 7ON, GOL
 |
Crystal Structure Of Sars-Cov-2 Main Protease M49T Mutant In Complex With Leritrelvir
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.70 Å Release Date: 2026-06-03 Classification: VIRAL PROTEIN Ligands: A1EN0, GOL |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2026-06-03
Ligands: A1EN0, GOL
 |
Crystal Structure Of Sars-Cov-2 Main Protease Q192L Mutant In Complex With Leritrelvir
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.70 Å Release Date: 2026-06-03 Classification: VIRAL PROTEIN Ligands: 7ON, GOL |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2026-06-03
Ligands: 7ON, GOL
 |
Crystal Structure Of Sars-Cov-2 Main Protease P168 Deletion And A173V Mutant In Complex With Leritrelvir
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.20 Å Release Date: 2026-06-03 Classification: VIRAL PROTEIN Ligands: 7ON, GOL |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2026-06-03
Ligands: 7ON, GOL
 |
Crystal Structure Of Sars-Cov-2 Main Protease Q189K Mutant In Complex With Leritrelvir
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.16 Å Release Date: 2026-06-03 Classification: VIRAL PROTEIN Ligands: 7ON |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2026-06-03
Ligands: 7ON
 |
Egfr Exon20 Insertion Mutant Asv Bound With (S)-3-((3-Chloro-2-Methoxyphenyl)Amino)-2-(3-((Tetrahydrofuran-2-Yl)Methoxy)Pyridin-4-Yl)-1,5,6,7-Tetrahydro-4H-Pyrrolo[3,2-C]Pyridin-4-One
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.50 Å Release Date: 2025-05-14 Classification: ONCOPROTEIN,TRANSFERASE/TRANSFERASE INHIBITOR Ligands: A1IMS, CL, EDO, GOL, PEG |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2025-05-14
Ligands: A1IMS, CL, EDO, GOL, PEG
 |
Egfr Exon20 Insertion Mutant Svd Bound With (S)-3-((3-Chloro-2-Methoxyphenyl)Amino)-2-(3-((Tetrahydrofuran-2-Yl)Methoxy)Pyridin-4-Yl)-1,5,6,7-Tetrahydro-4H-Pyrrolo[3,2-C]Pyridin-4-One
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.68 Å Release Date: 2025-05-14 Classification: ONCOPROTEIN,TRANSFERASE/TRANSFERASE INHIBITOR Ligands: A1IMS, EDO, GOL |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2025-05-14
Ligands: A1IMS, EDO, GOL
 |
Egfr Exon20 Insertion Mutant Svd Bound With Stx-721
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.78 Å Release Date: 2025-05-14 Classification: ONCOPROTEIN,TRANSFERASE/TRANSFERASE INHIBITOR Ligands: A1A4E, CL, EDO, GOL |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2025-05-14
Ligands: A1A4E, CL, EDO, GOL
 |
Wildtype Egfr Bound With (R)-3-((3-Chloro-2-Methoxyphenyl)Amino)-2-(3-((Tetrahydrofuran-2-Yl)Methoxy)Pyridin-4-Yl)-1,5,6,7-Tetrahydro-4H-Pyrrolo[3,2-C]Pyridin-4-One
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:3.12 Å Release Date: 2025-05-14 Classification: ONCOPROTEIN Ligands: A1ILZ |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2025-05-14
Ligands: A1ILZ